CDM-3008

small molecule with an imidazo(1,2-a)(1,8)naphthyridine scaffold

Also Known As:

2-(2,4-bis(trifluoromethyl)imidazo(1,2-a)(1,8)naphthyridin-8-yl)-1,3,4-oxadiazole; RO8191

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Inflammation (Inflammations) 02/01/2023 - "Furthermore, addition of RO8191 restored the effect of baricitinib on the induction of oxidative stress, inflammation and osteogenic differentiation of PDLSCs exposed to LPS. "
2.	Infections 01/01/2023 - "Additionally, RO8191 was capable to protect cells against CHIKV infection, inhibit entry by virucidal activity, and strongly impair post-entry steps of viral replication. " 01/01/2023 - "RO8191 inhibited CHIKV infection in BHK-21 and Vero-E6 cells with a selectivity index (SI) of 12.3 and 37.3, respectively. "

1.	baricitinib